TSX:TLRY (Aphria)
About TLRY
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products through Manitoba Harvest and beer through SweetWater.
Aphria (TSX: TLRY) Latest News
Dividend Stocks
4 Things to Love About Metro, Inc.’s Earnings
Dividend Stocks
Investor Caution: What Recent Pharmaceutical Changes Will Mean for These 2 Large Caps

Dividend Stocks
Why Metro, Inc. Should Top Your List of Canadian Grocers for 2018
Dividend Stocks
Jean Coutu Group PJC Inc. Results Take a Hit in the 3rd Quarter

Investing
Canada’s Best Brands Outperform the TSX in 2017
Investing
Metro, Inc.: Will its E-Commerce Efforts Be Enough to Offset Competition From Amazon.com. Inc.?
Dividend Stocks
This Pharmacy Chain Posted a Strong Q2 and Could See Many Growth Opportunities Ahead
Investing
Quebec’s Favourite Convenience Store Operator Just Got a Floor Price
Dividend Stocks
Jean Coutu Group PJC Inc. & Metro, Inc. Merge, as Expected
Dividend Stocks
Do Canadian Retailers Need Mergers and Acquisitions to Survive?
